Asessing coronary heart disease risk and managing lipids

Area of Science:

• Cardiology
• Clinical Biochemistry
• Preventive Medicine

Background:

• Elevated low-density lipoprotein (LDL) and low high-density lipoprotein (HDL) cholesterol are established risk factors for coronary heart disease (CHD).
• Current clinical guidelines prioritize LDL cholesterol for lipid-altering therapy.
• A significant number of patients developing CHD possess LDL and HDL levels within desirable or low-risk ranges, indicating limitations in standard lipid profiles for identifying all high-risk individuals.

Purpose of the Study:

• To discuss the clinical significance of lipoprotein subclasses in cardiovascular risk assessment.
• To review methods for measuring lipoprotein subclasses.
• To highlight the advantages of lipoprotein subclass analysis over standard lipid profiles.

Main Methods:

• Literature review on lipoprotein subclass analysis.
• Discussion of measurement techniques for lipoprotein subclasses.
• Comparison of lipoprotein subclass data with standard lipid profiles.

Main Results:

• Lipoprotein subclass analysis provides a more detailed view of lipid profiles than standard measurements.
• Standard lipid profiles may underestimate cardiovascular risk in certain patient groups.
• Lipoprotein subclasses can offer a more accurate identification of patients at high risk for CHD.

Conclusions:

• Assessing lipoprotein subclasses is clinically significant for a comprehensive understanding of cardiovascular risk.
• Lipoprotein subclass analysis enables a more efficacious therapeutic approach compared to standard lipid profiles.
• This advanced assessment aids in identifying high-risk patients who might be overlooked by conventional lipid testing.